{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:04:10Z","timestamp":1781301850726,"version":"3.54.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Professionals Resource Network, Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jns.2020.116714","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T11:19:24Z","timestamp":1580383164000},"page":"116714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Neuropsychological impairment associated with substance use by physicians"],"prefix":"10.1016","volume":"411","author":[{"given":"Alexandria G.","family":"Polles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle K.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R.","family":"Phalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Teitelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3613-7853","authenticated-orcid":false,"given":"Lisa J.","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jns.2020.116714_bb0005","first-page":"7","article-title":"A census of actively licensed physicians in the United States, 2016","volume":"103","author":"Young","year":"2017","journal-title":"J. Med. Reg."},{"key":"10.1016\/j.jns.2020.116714_bb0010","doi-asserted-by":"crossref","first-page":"a2038","DOI":"10.1136\/bmj.a2038","article-title":"Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States","volume":"337","author":"McLellan","year":"2008","journal-title":"BMJ."},{"issue":"7","key":"10.1016\/j.jns.2020.116714_bb0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0025-6196(11)60751-9","article-title":"Chemical dependency and the physician","volume":"84","author":"Berge","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jns.2020.116714_bb0020","author":"Federation of State Medical Boards"},{"issue":"10","key":"10.1016\/j.jns.2020.116714_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186902","article-title":"Assessment of fitness for duty of underperforming physicians: The importance of using appropriate norms","volume":"12","author":"Williams","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jns.2020.116714_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207874","article-title":"Importance of neuropsychological screening in physicians referred for performance concerns","volume":"13","author":"Williams","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2020.116714_bb0035","author":"Protenus"},{"issue":"4","key":"10.1016\/j.jns.2020.116714_bb0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tics.2005.02.008","article-title":"Neurocognitive insights into substance abuse","volume":"9","author":"Garavan","year":"2005","journal-title":"Trends Cogn. Sci."},{"issue":"3","key":"10.1016\/j.jns.2020.116714_bb0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S1355617706060486","article-title":"Executive dysfunction in substance dependent individuals during drug use and abstinence: an examination of the behavioral, cognitive and emotional correlates of addiction","volume":"12","author":"Verdejo-Garcia","year":"2006","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"3","key":"10.1016\/j.jns.2020.116714_bb0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neubiorev.2010.04.008","article-title":"What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?","volume":"35","author":"Fernandez-Serrano","year":"2011","journal-title":"Neurosci. Biobehav. R."},{"issue":"2","key":"10.1016\/j.jns.2020.116714_bb0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0893-133X(00)00097-X","article-title":"Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers","volume":"23","author":"Ornstein","year":"2000","journal-title":"Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jns.2020.116714_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:NERV.0000026647.71528.83","article-title":"Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse","volume":"14","author":"Verdejo-Garcia","year":"2004","journal-title":"Neuropsychol. Rev."},{"issue":"2","key":"10.1016\/j.jns.2020.116714_bb0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1151\/spp07324","article-title":"Imaging the addicted human brain","volume":"3","author":"Fowler","year":"2007","journal-title":"Sci. Pract. Perspect."},{"issue":"9 Pt A","key":"10.1016\/j.jns.2020.116714_bb0070","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.neubiorev.2013.04.007","article-title":"Recovering from cocaine: insights from clinical and preclinical investigations","volume":"37","author":"Hanlon","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.jns.2020.116714_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: implications for treatment","volume":"1","author":"Kosten","year":"2002","journal-title":"Sci. Pract. Perspect."},{"key":"10.1016\/j.jns.2020.116714_bb0080","series-title":"https:\/\/www.asam.org\/docs\/default-source\/practice-support\/guidelines-and-consensus-docs\/asam-national-practice-guideline-supplement.pdf: American Association of Addiction Medicine","author":"The ASAM National Practice Guidelines for the Use of Medications in the Treatment of Addiction Involving Opioid Use","year":"2015"},{"key":"10.1016\/j.jns.2020.116714_bb0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fncel.2015.00162","article-title":"The role of the GABA system in amphetamine-type stimulant use disorders","volume":"9","author":"Jiao","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"8","key":"10.1016\/j.jns.2020.116714_bb0090","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.neubiorev.2013.07.003","article-title":"Characterizing the cognitive effects of cocaine: a comprehensive review","volume":"37","author":"Spronk","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.jns.2020.116714_bb0095","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/ADM.0000000000000066","article-title":"Cocaine and cognition: a systematic quantitative review","volume":"8","author":"Potvin","year":"2014","journal-title":"J. Addict. Med."},{"issue":"5","key":"10.1016\/j.jns.2020.116714_bb0100","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.addbeh.2006.06.032","article-title":"Cognitive impulsivity in cocaine and heroin polysubstance abusers","volume":"32","author":"Verdejo-Garcia","year":"2007","journal-title":"Addict. Behav."},{"issue":"2","key":"10.1016\/j.jns.2020.116714_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.drugalcdep.2005.02.002","article-title":"Deficits in response inhibition associated with chronic methamphetamine abuse","volume":"79","author":"Monterosso","year":"2005","journal-title":"Drug Alcohol Depend."},{"issue":"12","key":"10.1016\/j.jns.2020.116714_bb0110","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited-will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction."},{"issue":"1","key":"10.1016\/j.jns.2020.116714_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use - A meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"Cns Drugs."},{"issue":"7","key":"10.1016\/j.jns.2020.116714_bb0120","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1017\/S0033291703008213","article-title":"Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life","volume":"33","author":"Curran","year":"2003","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.jns.2020.116714_bb0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/gps.930070205","article-title":"Cognitive Improvement Following Benzodiazepine Discontinuation in Elderly Nursing-Home Residents","volume":"7","author":"Salzman","year":"1992","journal-title":"Int. J. Geriatr. Psychopharmacol."},{"key":"10.1016\/j.jns.2020.116714_bb0130","first-page":"9","article-title":"The effects of benzodiazepines on cognition","volume":"66","author":"Stewart","year":"2005","journal-title":"J. Clin. Psychiat."},{"issue":"2","key":"10.1016\/j.jns.2020.116714_bb0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1017\/S0033291700007911","article-title":"Cognitive impairment in long-term benzodiazepine users","volume":"18","author":"Golombok","year":"1988","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.jns.2020.116714_bb0140","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S0033291700026969","article-title":"Lack of cognitive recovery following withdrawal from long-term benzodiazepine use","volume":"24","author":"Tata","year":"1994","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.jns.2020.116714_bb0145","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/026988119801200403","article-title":"An examination of differences in the time course of oxazepam\u2019s effects on implicit vs explicit memory","volume":"12","author":"Buffett-Jerrott","year":"1998","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jns.2020.116714_bb0150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/026988119500900404","article-title":"Impairment of performance associated with long-term use of benzodiazepines","volume":"9","author":"Gorenstein","year":"1995","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jns.2020.116714_bb0155","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0887-6177(03)00096-9","article-title":"Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis","volume":"19","author":"Barker","year":"2004","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"4","key":"10.1016\/j.jns.2020.116714_bb0160","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1037\/1064-1297.8.4.483","article-title":"Abstinence symptoms during withdrawal from chronic marijuana use","volume":"8","author":"Kouri","year":"2000","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jns.2020.116714_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADM.0b013e31820c23fa","article-title":"An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions","volume":"5","author":"Crean","year":"2011","journal-title":"J. Addict. Med."},{"issue":"4","key":"10.1016\/j.jns.2020.116714_bb0170","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/sj.npp.1300620","article-title":"Acute marijuana effects on human risk taking","volume":"30","author":"Lane","year":"2005","journal-title":"Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jns.2020.116714_bb0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2004.04.009","article-title":"Long-term heavy marijuana users make costly decisions on a gambling task","volume":"76","author":"Whitlow","year":"2004","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.jns.2020.116714_bb0180","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jama.287.9.1123","article-title":"Cognitive functioning of long-term heavy cannabis users seeking treatment","volume":"287","author":"Solowij","year":"2002","journal-title":"Jama."},{"issue":"3","key":"10.1016\/j.jns.2020.116714_bb0185","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.drugalcdep.2008.01.009","article-title":"Cognitive deficits in marijuana users: Effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome","volume":"95","author":"Aharonovich","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.jns.2020.116714_bb0190","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.addbeh.2010.05.005","article-title":"The frontal assessment battery (FAB) reveals neurocognitive dysfunction in substance-dependent individuals in distinct executive domains: abstract reasoning, motor programming, and cognitive flexibility","volume":"35","author":"Cunha","year":"2010","journal-title":"Addict. Behav."},{"issue":"3","key":"10.1016\/j.jns.2020.116714_bb0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0376-8716(02)00334-4","article-title":"Early-onset cannabis use and cognitive deficits: what is the nature of the association?","volume":"69","author":"Pope","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.jns.2020.116714_bb0200","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/acer.13431","article-title":"Executive functions, memory, and social cognitive deficits and recovery in chronic alcoholism: a critical review to inform future research","volume":"41","author":"Le Berre","year":"2017","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"7","key":"10.1016\/j.jns.2020.116714_bb0205","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1530-0277.2007.00418.x","article-title":"Genuine episodic memory deficits and executive dysfunctions in alcoholic subjects early in abstinence","volume":"31","author":"Pitel","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.jns.2020.116714_bb0210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0376-8716(94)01072-S","article-title":"Neuropsychological performance of recently abstinent alcoholics and cocaine abusers","volume":"37","author":"Beatty","year":"1995","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.jns.2020.116714_bb0215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1064-1297.10.3.193","article-title":"Neurocognitive impairment associated with alcohol use disorders: Implications for treatment","volume":"10","author":"Bates","year":"2002","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jns.2020.116714_bb0220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11065-007-9038-6","article-title":"Alcohol: effects on neurobehavioral functions and the brain","volume":"17","author":"Oscar-Berman","year":"2007","journal-title":"Neuropsychol. Rev."},{"issue":"6","key":"10.1016\/j.jns.2020.116714_bb0225","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/hep.23216","article-title":"Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy","volume":"50","author":"Bajaj","year":"2009","journal-title":"Hepatology."},{"issue":"2","key":"10.1016\/j.jns.2020.116714_bb0230","first-page":"151","article-title":"The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies","volume":"31","author":"Ridola","year":"2018","journal-title":"Ann. Gastroenterol."},{"issue":"8","key":"10.1016\/j.jns.2020.116714_bb0235","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/01.alc.0000175013.50644.61","article-title":"Alcoholic neurobiology: changes in dependence and recovery","volume":"29","author":"Crews","year":"2005","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.jns.2020.116714_bb0240","first-page":"473","article-title":"Neuropsychological vulnerability to alcoholism: evidence from neuroimaging studies","volume":"34","author":"Sullivan","year":"2000","journal-title":"NIAAA Res. Mono."},{"issue":"3","key":"10.1016\/j.jns.2020.116714_bb0245","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/01688639708403866","article-title":"Effects of abstinence and relapse upon neuropsychological function and cerebral glucose metabolism in severe chronic alcoholism","volume":"19","author":"Johnson-Greene","year":"1997","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"12","key":"10.1016\/j.jns.2020.116714_bb0250","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.biopsych.2005.05.038","article-title":"Monitoring the effects of chronic alcohol consumption and abstinence on brain metabolism: a longitudinal proton magnetic resonance spectroscopy study","volume":"58","author":"Ende","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2020.116714_bb0255","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1530-0277.1995.tb00992.x","article-title":"Brain proton magnetic resonance spectroscopy studies in recently abstinent alcoholics","volume":"19","author":"Martin","year":"1995","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.jns.2020.116714_bb0260","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1530-0277.1999.tb04038.x","article-title":"Localized proton magnetic resonance spectroscopy of the cerebellum in detoxifying alcoholics","volume":"23","author":"Seitz","year":"1999","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"9","key":"10.1016\/j.jns.2020.116714_bb0265","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.neubiorev.2012.06.006","article-title":"Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis","volume":"36","author":"Baldacchino","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.jns.2020.116714_bb0270","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.drugalcdep.2004.11.006","article-title":"Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers","volume":"78","author":"Verdejo","year":"2005","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.jns.2020.116714_bb0275","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11065-007-9041-y","article-title":"Neuropsychological consequences of opiate use","volume":"17","author":"Gruber","year":"2007","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.jns.2020.116714_bb0280","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jsat.2018.03.001","article-title":"Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review","volume":"89","author":"Maglione","year":"2018","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.jns.2020.116714_bb0285","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1747-597X-4-6","article-title":"Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: longitudinal change in comparison to healthy individuals","volume":"4","author":"Rapeli","year":"2009","journal-title":"Subst. Abuse. Treat Prev. Policy."},{"issue":"6","key":"10.1016\/j.jns.2020.116714_bb0290","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/JCP.0b013e31818a6d38","article-title":"Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial","volume":"28","author":"Soyka","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.jns.2020.116714_bb0295","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugalcdep.2011.10.022","article-title":"Road traffic crashes and prescribed methadone and buprenorphine: a French registry-based case-control study","volume":"123","author":"Corsenac","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jns.2020.116714_bb0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neubiorev.2016.11.008","article-title":"Neuropsychological functioning and chronic methadone use: A systematic review and meta-analysis","volume":"73","author":"Baldacchino","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.jns.2020.116714_bb0305","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.mayocp.2011.09.007","article-title":"Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversy","volume":"87","author":"Hamza","year":"2012","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.jns.2020.116714_bb0310","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mayocp.2012.02.002","article-title":"Opioid-Abusing Health Care Professionals: Options for Treatment and Returning to Work After Treatment","volume":"87","author":"Seppala","year":"2012","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.jns.2020.116714_bb0315","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jsat.2008.01.004","article-title":"Setting the standard for recovery: Physicians\u2019 Health Programs","volume":"36","author":"DuPont","year":"2009","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.jns.2020.116714_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2009.03.010","article-title":"How are addicted physicians treated? A national survey of Physician Health Programs","volume":"37","author":"DuPont","year":"2009","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.jns.2020.116714_bb0325","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsat.2016.02.004","article-title":"Outcomes for physicians with opioid dependence treated without agonist pharmacotherapy in physician health programs","volume":"64","author":"Merlo","year":"2016","journal-title":"J. Subst. Abus. Treat."},{"issue":"5","key":"10.1016\/j.jns.2020.116714_bb0330","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jns.2020.116714_bb0335","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0376-8716(02)00013-3","article-title":"Cognitive impairment in methadone maintenance patients","volume":"67","author":"Mintzer","year":"2002","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.jns.2020.116714_bb0340","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1907875","article-title":"Practicing what we preach \u2014 ending physician health program bans on opioid-agonist therapy","volume":"381","author":"Beletsky","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.116714_bb0345","series-title":"https:\/\/www.faa.gov\/pilots\/safety\/pilotsafetybrochures\/media\/OpioidEpidemicAndAviation.pdf: Federal Aviation Administration","author":"Opioid Epidemic and Aviation","year":"2019"},{"key":"10.1016\/j.jns.2020.116714_bb0350","author":"Questions and Answers from Webinar: Medication Assisted Treatment: Special Anti-Discrimination Issues","year":"2010"},{"issue":"12","key":"10.1016\/j.jns.2020.116714_bb0355","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jamapsychiatry.2017.3206","article-title":"Effectiveness of injectable extended-release naltrexone vs daily buprenorphine-naloxone for opiod dependence: a randomized clinical noninferiority trial","volume":"74","author":"Tanum","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2020.116714_bb0360","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/ADM.0b013e31821852a0","article-title":"Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practice","volume":"5","author":"Merlo","year":"2011","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.jns.2020.116714_bb0365","author":"SAMHSA TIP 45"},{"key":"10.1016\/j.jns.2020.116714_bb0370","author":"SAMHSA TIP 63"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20300502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20300502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:49:42Z","timestamp":1758383382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20300502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":74,"alternative-id":["S0022510X20300502"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.116714","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropsychological impairment associated with substance use by physicians","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.116714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116714"}}